Cart
sales@molnova.com
Corysamine chloride
CAS No. 11028-77-6
Corysamine chloride( CORYSAMINE CHLORIDE(RG) )
Catalog No. M23304 CAS No. 11028-77-6
Corysamine chloride was identified to inhibit the activity of ACHE.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 291 | In Stock |
|
| 10MG | 432 | In Stock |
|
| 25MG | 707 | In Stock |
|
| 50MG | 972 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCorysamine chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCorysamine chloride was identified to inhibit the activity of ACHE.
-
DescriptionCorysamine chloride was identified to inhibit the activity of ACHE.
-
In Vitro——
-
In Vivo——
-
SynonymsCORYSAMINE CHLORIDE(RG)
-
PathwayOthers
-
TargetOther Targets
-
RecptorACHE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number11028-77-6
-
Formula Weight369.8
-
Molecular FormulaC20H16ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1c(ccc2c3OCO2)c3c[n+](CC2)c1-c1c2cc2OCOc2c1.[Cl-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang Y , Kang J . Screening of the active ingredients in natural products by capillary electrophoresis and high performance liquid chromatography-mass spectrometry[J]. Se pu = Chinese journal of chromatography / Zhongguo hua xue hui, 2013, 31(7):640-645.
molnova catalog
related products
-
Talmetacin
Talmetacin has anti-inflammatory and analgesic and anti-tumour activity and can be used to study cardiovascular disease.
-
Bofutrelvir
Bofutrelvir (FB2001) is a SARS-CoV-2 3CL protease inhibitor with antiviral activity for the study of novel coronavirus pneumonia (COVID-19) infections.
-
LY-3475070
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
